Clal Biotechnology reported ILS-5.15M in Interest Income for its fiscal quarter ending in December of 2022.





Interest Income Change Date
Arca Biopharma USD 4.09M 441K Mar/2025
aTyr Pharma USD 7.84K 3.09K Sep/2025
Bio Path USD 4K 0 Dec/2024
Cara Therapeutics USD 347K 74K Mar/2025
Compugen USD 954K 116K Sep/2025
Immunic USD -0.24 0.03 Sep/2024
RedHill Biopharma USD 7.1M 14.49M Jun/2023